Aflatoxin B1 activation in human lung

Toxicology and Applied Pharmacology

Volumn 144, Issue 1, 1997, Pages 88-95

  Kelly, Jack D ^a   Eaton, David L ^b   Guengerich, F Peter ^c   Coulombe Jr , Roger A ^a  

^a UTAH STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; CARCINOGEN; CYTOCHROME C OXIDASE; UNSPECIFIC MONOOXYGENASE; AFLATOXIN B1 8,9 DICHLORIDE; AFLATOXIN B1-8,9-DICHLORIDE; CYP3A PROTEIN, HUMAN; CYTOCHROME P450; DRUG DERIVATIVE; MIXED FUNCTION OXIDASE;

ARTICLE; DRUG ACTIVATION; DRUG METABOLISM; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG PARENCHYMA; MICROSOME; BIOSYNTHESIS; BIOTRANSFORMATION; ENZYMOLOGY; LUNG; METABOLISM;

STAPHYLOCOCCUS PHAGE 3A;

AFLATOXIN B1; BIOTRANSFORMATION; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; LUNG; MICROSOMES; MIXED FUNCTION OXYGENASES;

EID: 0031133772     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8117     Document Type: Article

References (54)

1. Aguilar F., Harris C. C., Sun T., Hollstein M., Cerutti P. Geographic variation of p53 mutational profile in nonmalignant human liver. Science. 264:1994;1317-1319.
2. 1. Proc. Natl. Acad. Sci. USA. 87:1990;4790-4793.
3. 11. Cancer Res. 39:1979;694-698.
4. 1. Carcinogenesis (Lond.). 12:1991;305-310.
5. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantaties of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
6. Burg W. R., Shotwell O. R., Saltzman B. E. Measurements of airborne aflatoxins during the handling of contaminated corn. Am. Ind. Hyg. Assoc. J. 42:1981;1-11.
7. 1. The Toxicology of Aflatoxins, Human Health, Veterinary and Agricultural Significance. 1994;Academic Press, San Diego. p. 89-101.
8. 1. Cancer Res. 46:1986;4091-4096.
9. 1. Toxicol. Appl. Pharmacol. 109:1991;196-206.
10. Crespi C. L., Langenbach R., Rudo K., Chen Y.-T., Davies R. L. Transection of a human cytochrome P-450 gene into the human lymphoblastoid cell line, AHH-1, and use of the recombinant cell line in gene mutation assays. Carcinogenesis (Lond.). 10:1989;295-301.
11. Daujat M., Pichard L., Fabre I., Pineau T., Fabre G., Bonfils C., Maurel P. Induction protocols for cytochrome P450IIIAin vivo. Methods Enzymol. 206:1991;345-353.
12. Deger G. E. Aflatoxin-human colon carcinogenesis? Ann. Int. Med. 85:1975;204-205.
13. Dvorackova I. Aflatoxin inhalation and alveolar cell carcinoma. Brit. Med. J. 1:1976;691.
14. Eaton D. L., Ramsdell H. S., Neal G. E. Biotransformation of aflatoxins. Eaton D. L., Groopman J. D. The Toxicology of Aflatoxins, Human Health, Veterinary and Agricultural Significance. 1994;45-72 Academic Press, San Diego.
15. Enwonwu C. O. The role of dietary aflatoxin in the genesis of hepatocellular cancer in developing countries. Lancet. 1984;956-958.
16. 1. Cold Spring Harbor Symp. Quant. Biol. 47:1983;327-337.
17. 1. Proc. Natl. Acad. Sci. USA. 87:1990;8306-8310.
18. 1. Cancer Res. 54:1994;101-108.
19. Gonzalez F. J. Molecular biology of human xenobiotic-metabolizing cytochromes P450: Role of vaccinia virus cDNA expression in evaluating catalytic function. Toxicology. 82:1993;77-88.
20. Guengerich F. P. Mechanism-based inactivation of human liver cytochrome P450 IIIA4 by gestodene. Chem. Res. Toxicol. 3:1990;363-371.
21. Harrison J. C., Garner R. C. Immunological and HPLC detection of aflatoxin adducts in human tissues after an acute poisoning incident in S.E. Asia. Carcinogenesis (Lond.). 12:1991;741-743.
22. Hayes R. B., Nieuwenhuize J. P., Raatgever J. W., Ten Kate F. J. W. Aflatoxin exposures in the industrial setting: An epidemiology study of mortality. Food Chem. Tox. 22:1984;39-43.
23. Laemmli U. K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature. 227:1970;680-683.
24. 1. Prog. Clin. Biol. Res. 376:1992a;203-222.
25. 1. Mol. Carcinogenesis (Lond.). 6:1992b;159-172.
26. 1. Proc. Natl. Acad. Sci. USA. 87:1990;1104-1108.
27. McMahon G., Davis E. F., Wogan G. N. Characterization of c-Ki-ras oncogene alleles by direct sequencing of enzymatically-amplified DNA from carcinogen-induced tumors. Proc. Natl. Acad. Sci. USA. 84:1987;4974-4978.
28. McMillian W. A., Wilson D. M., Widstrom N. W. Insect damage, aspergillus ear mold, and aflatoxin contamination in south Georgia corn field in 1977. J. Environ. Qual. 7:1978;565.
29. Olsen J. J., Dragsted L., Autrup H. Cancer risk and occupational exposure to aflatoxins in Denmark. Br. J. Cancer. 58:1988;392-396.
30. 1. Cancer Res. 50:1990;615-620.
31. 1. Toxicol. Appl. Pharmacol. 108:1991;436-447.
32. 1. Chem. Res. Toxicol. 5:1992a;333-335.
33. 1exoendo. Chem. Res. Toxicol. 5:1992b;470-478.
34. 11. Chem. Res. Toxicol. 5:1992c;202-210.
35. Robertson I. G. C., Guthenberg C., Mannervik B., Jernstrom B. Differences in stereoselectivity and catalytic efficiency of three human glutathione transferases in the conjugation of glutatione with 7β,8α-dihydroxy-9α,10α-oxy-7,8,9,10- tetrahydrobenzo(α)pyrene. Cancer Res. 46:1986;2220-2224.
36. Sabourin P. J., Tynes R. E., Philpot R. N., Winquist S., Dahl A. R. Distribution of microsomal monooxygenases in the rabbit respiratory tract. Drug Metab. Disp. 16:1988;557-562.
37. Serabjit-Singh C., Wolf C. R., Philpot R. M., Plopper C. G. Cytochrome P-450: Localization in rabbit lung. Science. 207:1980;469-1470.
38. Shank R. C., Bhamarapravati N., Gordon J. E., Wogan G. N. Dietary aflatoxins and human liver cancer. IV. Incidence of primary liver cancer in two municipal populations of Thailand. Food. Cosmet. Toxicol. 10:1972;171-179.
39. NF. Proc. Natl. Acad. Sci. USA. 86:1989;462-465.
40. Shimada T., Iwasaki M., Martin M. V., Guengerich F. P. Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected byumuSalmonella typhimurium. Cancer Res. 49:1989;3218-3228.
41. Shimada T., Martin M. V., Pruess-Schwartz D., Marnett L. J., Guengerich F. P. Roles of individual human cytochrome P-450 enzyzmes in the bioactivation of benzo(a)pyrene, 7-8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. Cancer Res. 49:1989;6304-6312.
42. Shimada T., Yun C.-H., Yamazaki H., Gautier J., Beaune P. H., Guengerich F. P. Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of Chemical carcinogens. Mol. Pharmacol. 41:1992;856-864.
43. Sorenson W. G., Simpson J. P., Peach M. J., Thedell T. D., Olenchock S. A. Aflatoxin in respirable corn dust particles. J. Toxicol. Environ. Health. 7:1981;669-672.
44. Sorokin S. P. The cells of the lung. Nettessheim P., Hanna M. G., Deatherage J. W. Morphology of Experimental Respiratory Carcinogenesis. 1970;23-44 US Atomic Energy Commission Symposium Series, Oak Ridge.
45. 1. Carcinogenesis (Lond.). 11:1982;1345-1348.
46. Van Nieuwenhuize J. P., Herber R. F. M., de Bruin A., Meyer P. B., Duba W. C. Aflatoxins - Epidemiological study on the carcinogenecity of prolonged exposure to low levels among the workers of a plant. Tijdschr. Soc. Geneesk. 51:1973;754-760.
47. Wheeler C. W., Guenthner T. M. Spectroscopic quantitation of cytochrome P-450 in human lung microsomes. J. Biochem. Toxicol. 5:1990;269-272.
48. Wheeler C. W., Park S. S., Guenthner T. M. Immunochemical analysis of a cytochrome P-450IAI homologue in human lung microsomes. Mol. Pharmacol. 38:1990;634-643.
49. Wheeler C. W., Wrighton S. A., Guenthner T. M. Detection of human lung cytochrome P450 that are immunochemically related to cytochrome P450IIEI and cytochrome P450IIIA. Biochem. Pharmacol. 44:1992;183-186.
50. 1. J. Natl. Cancer Inst. 40:1968;1195-1197.
51. Wild C. P., Shrestha S. M., Anwar W. A., Montesano R. Field studies on aflatoxin exposure, metabolism and induction of genetic alterations in relation to HBV infection and hepatocellular carcinoma in The Gambia and Thailand. Toxicol. Lett. 64/65:1992;455-461.
52. 1. Cancer Res. 50:1990;2493-2498.
53. Wogan G. N. Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Res. 52:1992;2114s-2118s.
54. Wrighton S. A., Brian W. R., Sari M. A., Iwasaki M., Guengerich F. P., Raucy J. L., Molowa D. T., Vandenbranden M. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5. Mol. Pharmacol. 38:1990;207-213.